Literature DB >> 28402724

Carbapenem-resistant Enterobacteriaceae: What we know and what we need to know.

David van Duin1.   

Abstract

Entities:  

Keywords:  antibiotic; carbapenem-resistant Enterobacteriaceae; carbapenemases; infection; multidrug resistance

Mesh：

Substances：

Year:  2017        PMID： 28402724      PMCID： PMC5477690          DOI： 10.1080/21505594.2017.1306621

Source DB:  PubMed          Journal:  Virulence        ISSN： 2150-5594            Impact factor:   5.882


× No keyword cloud information.
  22 in total

1.  Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015.

Authors:  Barbara Albiger; Corinna Glasner; Marc J Struelens; Hajo Grundmann; Dominique L Monnet
Journal:  Euro Surveill       Date:  2015

Review 2.  Clinical and laboratory considerations for the rapid detection of carbapenem-resistant Enterobacteriaceae.

Authors:  Ritu Banerjee; Romney Humphries
Journal:  Virulence       Date:  2016-05-11       Impact factor: 5.882

3.  Epidemiology and clinical outcomes of patients with carbapenem-resistant Klebsiella pneumoniae bacteriuria.

Authors:  Zubair A Qureshi; Alveena Syed; Lloyd G Clarke; Yohei Doi; Ryan K Shields
Journal:  Antimicrob Agents Chemother       Date:  2014-03-17       Impact factor: 5.191

4.  Ceftazidime-Avibactam for Treatment of Carbapenem-Resistant Enterobacteriaceae Bacteremia.

Authors:  Gary Wu; Teena Abraham; Spencer Lee
Journal:  Clin Infect Dis       Date:  2016-07-17       Impact factor: 9.079

5.  Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia.

Authors:  Pranita D Tamma; Katherine E Goodman; Anthony D Harris; Tsigereda Tekle; Ava Roberts; Abimbola Taiwo; Patricia J Simner
Journal:  Clin Infect Dis       Date:  2016-11-09       Impact factor: 9.079

6.  Surveillance of carbapenem-resistant Klebsiella pneumoniae: tracking molecular epidemiology and outcomes through a regional network.

Authors:  David van Duin; Federico Perez; Susan D Rudin; Eric Cober; Jennifer Hanrahan; Julie Ziegler; Raymond Webber; Jacqueline Fox; Pamela Mason; Sandra S Richter; Marianne Cline; Geraldine S Hall; Keith S Kaye; Michael R Jacobs; Robert C Kalayjian; Robert A Salata; Julia A Segre; Sean Conlan; Scott Evans; Vance G Fowler; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2014-05-05       Impact factor: 5.191

7.  Impact of therapy and strain type on outcomes in urinary tract infections caused by carbapenem-resistant Klebsiella pneumoniae.

Authors:  David van Duin; Eric Cober; Sandra S Richter; Federico Perez; Robert C Kalayjian; Robert A Salata; Scott Evans; Vance G Fowler; Keith S Kaye; Robert A Bonomo
Journal:  J Antimicrob Chemother       Date:  2014-12-09       Impact factor: 5.790

8.  Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections.

Authors:  Ryan K Shields; Brian A Potoski; Ghady Haidar; Binghua Hao; Yohei Doi; Liang Chen; Ellen G Press; Barry N Kreiswirth; Cornelius J Clancy; M Hong Nguyen
Journal:  Clin Infect Dis       Date:  2016-09-13       Impact factor: 9.079

Review 9.  Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor Combinations.

Authors:  David van Duin; Robert A Bonomo
Journal:  Clin Infect Dis       Date:  2016-04-20       Impact factor: 9.079

Review 10.  Role of newer and re-emerging older agents in the treatment of infections caused by carbapenem-resistant Enterobacteriaceae.

Authors:  Joshua T Thaden; Jason M Pogue; Keith S Kaye
Journal:  Virulence       Date:  2016-07-06       Impact factor: 5.882
View more
  7 in total

1.  Parallel Reaction Monitoring Mass Spectrometry for Rapid and Accurate Identification of β-Lactamases Produced by Enterobacteriaceae.

Authors:  Yun Lu; Xinxin Hu; Jing Pang; Xiukun Wang; Guoqing Li; Congran Li; Xinyi Yang; Xuefu You
Journal:  Front Microbiol       Date:  2022-06-20       Impact factor: 6.064

2.  Active Screening of Intestinal Colonization of Carbapenem-Resistant Enterobacteriaceae for Subsequent Bloodstream Infection in Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Weijie Cao; Jieyong Zhang; Zhilei Bian; Li Li; Suping Zhang; Yang Qin; Dingming Wan; Zhongxing Jiang; Ran Zhang
Journal:  Infect Drug Resist       Date:  2022-10-18       Impact factor: 4.177

3.  Molecular characterization of carbapenemases of clinical Acinetobacter baumannii-calcoaceticus complex isolates from a University Hospital in Tunisia.

Authors:  Hadhemi Ben Cheikh; Sara Domingues; Eduarda Silveira; Yosr Kadri; Natasha Rosário; Maha Mastouri; Gabriela Jorge Da Silva
Journal:  3 Biotech       Date:  2018-06-27       Impact factor: 2.406

4.  Carbapenem-resistant bacteria on hand-held and hands-free electronic devices of healthcare workers and non-healthcare workers in Delhi, India.

Authors:  Manpreet Bhalla; Amit Aggarwal; Khan Hena Fatima
Journal:  Infect Prev Pract       Date:  2021-07-21

Review 5.  Multidrug-Resistant Bacteria: Their Mechanism of Action and Prophylaxis.

Authors:  Alok Bharadwaj; Amisha Rastogi; Swadha Pandey; Saurabh Gupta; Jagdip Singh Sohal
Journal:  Biomed Res Int       Date:  2022-09-05       Impact factor: 3.246

6.  Assessing Colistin Resistance by Phenotypic and Molecular Methods in Carbapenem-resistant Enterobacterales in a Tertiary Care Hospital in Pakistan.

Authors:  Warda Furqan; Sakhawat Ali; Javaid Usman; Faisal Hanif; Afnan Naeem; Amnah Nasrullah; Nadia Tayyab
Journal:  Infect Drug Resist       Date:  2022-10-10       Impact factor: 4.177

Review 7.  Resistance of Gram-Negative Bacteria to Current Antibacterial Agents and Approaches to Resolve It.

Authors:  Zeinab Breijyeh; Buthaina Jubeh; Rafik Karaman
Journal:  Molecules       Date:  2020-03-16       Impact factor: 4.411
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.